Publications

2022

Moscat J, Linares JF, Duran A, Diaz-Meco MT. Protein kinase Cλ/ι in cancer: a contextual balance of time and signals. Trends Cell Biol. 2022;32(12):1023-1034.
Butler-Laporte G, Gonzalez-Kozlova E, Su C-, Zhou S, Nakanishi T, Brunet-Ratnasingham E, et al. Correction: The dynamic changes and sex differences of 147 immune-related proteins during acute COVID-19 in 580 individuals. Clin Proteomics. 2022;19(1):40.
Germanos AA, Arora S, Zheng Y, Goddard ET, Coleman IM, Ku AT, et al. Defining cellular population dynamics at single-cell resolution during prostate cancer progression. Elife. 2022;11.
Satlin MJ, Chen L, Douglass C, Hovan M, Davidson E, Soave R, et al. Reply to Caldwell et al. Clin Infect Dis. 2022;75(1):180-181.
Marchionni L, Lobo FP, Kostadinov R, Serra A, Besso FG, Deaglio S, et al. Donor-derived acute myeloid leukemia in solid organ transplantation. Am J Transplant. 2022;22(12):3111-3119.
Liu Y-, Illar GM, Amri RA, Canady BC, Rea B, Yatsenko SA, et al. Therapy-related myeloid neoplasms with different latencies: a detailed clinicopathologic analysis. Mod Pathol. 2022;35(5):625-631.
Rodino KG, Peaper DR, Kelly BJ, Bushman F, Marques A, Adhikari H, et al. Partial ORF1ab Gene Target Failure with Omicron BA.2.12.1. medRxiv. 2022.
Charpentier M, Spada S, Van Nest SJ, Demaria S. Radiation therapy-induced remodeling of the tumor immune microenvironment. Semin Cancer Biol. 2022;86(Pt 2):737-747.
Fowler FC, Chen B-, Zolnerowich N, Wu W, Pavani R, Paiano J, et al. DNA-PK promotes DNA end resection at DNA double strand breaks in G0 cells. Elife. 2022;11.
Harris AE, Metzler VM, Lothion-Roy J, Varun D, Woodcock CL, Haigh DB, et al. Exploring anti-androgen therapies in hormone dependent prostate cancer and new therapeutic routes for castration resistant prostate cancer. Front Endocrinol (Lausanne). 2022;13:1006101.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700